New software, created by scientists at Imperial College London and the University of Edinburgh, has been able to identify and measure the severity of small vessel disease, one of the commonest causes of stroke and dementia. The study, published in Radiology, took place at Charing Cross Hospital, part of Imperial College Healthcare NHS Trust.
Researchers say that this technology can help clinicians to administer the best treatment to patients more quickly in emergency settings – and predict a person’s likelihood of developing dementia. The development may also pave the way for more personalised medicine.
Dr Paul Bentley, lead author and Clinical Lecturer at Imperial College London, said:
“This is the first time that machine learning methods have been able to accurately measure a marker of small vessel disease in patients presenting with stroke or memory impairment who undergo CT scanning. Our technique is consistent and achieves high accuracy relative to an MRI scan – the current gold standard technique for diagnosis. This could lead to better treatments and care for patients in everyday practice.”
Professor Joanna Wardlaw, Head of Neuroimaging Sciences at the University of Edinburgh, added: “This is a first step in making a scan reading tool that could be useful in mining large routine scan datasets and, after more testing, might aid patient assessment at hospital admission with stroke.”
Small vessel disease (SVD) is a very common neurological disease in older people that reduces blood flow to the deep white matter connections of the brain, damaging and eventually killing the brain cells. It causes stroke and dementia as well as mood disturbance. SVD increases with age but is accelerated by hypertension and diabetes.
At the moment, doctors diagnose SVD by looking for changes to white matter in the brain during MRI or CT scans. However, this relies on a doctor gauging from the scan how far the disease has spread. In CT scans it is often difficult to decide where the edges of the SVD are, making it difficult to estimate the severity of the disease, explains Dr Bentley.
Although MRI can detect and measure SVD more sensitively it is not the most common method used due to scanner availability, and suitability for emergency or older patients.
Dr Bentley added: “Current methods to diagnose the disease through CT or MRI scans can be effective, but it can be difficult for doctors to diagnose the severity of the disease by the human eye. The importance of our new method is that it allows for precise and automated measurement of the disease. This also has applications for widespread diagnosis and monitoring of dementia, as well as for emergency decision-making in stroke.”
Dr Bentley explains that this software could help influence doctors decision-making in emergency neurological conditions and lead to more personalised medicine. For example, in stroke, treatments such as ‘clot busting medications’ can be quickly administered to unblock an artery. However, these treatments can be hazardous by causing bleeding, which becomes more likely as the amount of SVD increases. The software could be applied in future to estimate the likely risk of haemorrhage in patients and doctors can decide on a personal basis, along with other factors, whether to treat or not with clot busters.
He also suggests that the software can help quantify the likelihood of patients developing dementia or immobility, due to slowly progressive SVD. This would alert doctors to potentially reversible causes such as high blood pressure or diabetes.
The study used historical data of 1082 CT scans of stroke patients across 70 hospitals in the UK between 2000-2014, including cases from the Third International Stroke Trial. The software identified and measured a marker of SVD, and then gave a score indicating how severe the disease was ranging from mild to severe. The researchers then compared the results to a panel of expert doctors who estimated SVD severity from the same scans. The level of agreement of the software with the experts was as good as agreements between one expert with another.
Additionally, in 60 cases they obtained MRI and CT in the same subjects, and used the MRI to estimate the exact amount of SVD. This showed that the software is 85 per cent accurate at predicting how severe SVD is.
The team are now using similar methods to measure the amount of brain shrinkage and other types of conditions commonly diagnosed on brain CT
Learn more: Artificial Intelligence improves stroke and dementia diagnosis in brain scans
The Latest on: Artificial intelligence diagnostics
[google_news title=”” keyword=”artificial intelligence diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial intelligence diagnostics
- Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insighton April 25, 2024 at 10:05 pm
Quest Diagnostics Inc demonstrates robust financial performance with significant revenue from its DIS business. Recent acquisitions and the Invigorate program highlight the company's strategic growth ...
- The Impact of Artificial Intelligence on Job Market Trendson April 25, 2024 at 3:49 am
Are robots taking over our jobs? Will artificial intelligence make human labor obsolete? These questions have been wandering over the job market for years, sparking debates and fears about the future ...
- Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping reviewon April 24, 2024 at 5:39 pm
This scoping review of randomised controlled trials on artificial intelligence (AI) in clinical practice reveals an expanding interest in AI across clinical specialties and locations. The USA and ...
- Quest Diagnostics Beats Q1 Estimates; Raises Guidanceon April 24, 2024 at 9:57 am
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
- Artificial intelligence can evaluate cardiovascular risk during CT scanon April 24, 2024 at 7:25 am
A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography ...
- Artificial Intelligence Helps Detect Dry Eye Diseaseon April 23, 2024 at 11:07 am
AI's ongoing learning process acts as a catalyst, driving research forward by contributing to predictive models for dry eye disease.
- Artificial intelligence to be used for the detection of common eye diseaseon April 23, 2024 at 6:14 am
In this study, researchers aim to use artificial intelligence (AI) to aid in early screening ... “However, there are still challenges for engineers to select the diagnostic standards and combinations ...
- Artificial Intelligence and Machine Learning – Webinars and Online Eventson April 20, 2024 at 2:17 pm
In this webinar, Dr. Luciane Kagohara from Johns Hopkins Medicine will discuss a novel artificial intelligence method integrating ... enabling for the next generation of diagnostic tools which could ...
- The Role Of Artificial Intelligence In Optimising Electric Vehicle Performanceon April 19, 2024 at 6:30 am
Through its capacity to process massive datasets and discern patterns in real-time, AI empowers EV technology with informed decision-making capabilities.
via Bing News